Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cytarabine

"Cytarabine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)


This graph shows the total number of publications written about "Cytarabine" by people in Harvard Catalyst Profiles by year, and whether "Cytarabine" was a major or minor topic of these publication.
Bar chart showing 268 publications over 30 distinct years, with a maximum of 16 publications in 2017
To see the data from this visualization as text, click here.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.